Search

Search Constraints

You searched for: Author/Creator Reingold, Arthur

Search Results

1. 1436. Risk Factors for Invasive Pneumococcal Disease in Adults ≥65 Years Old Following Pneumococcal Conjugate Vaccine Recommendation. (26th November 2018)

2. 151. Evaluation of Pneumococcal Vaccine Effectiveness Against Invasive Pneumococcal Disease Among US Medicare Beneficiaries ≥65 Years Old. (26th November 2018)

3. 1877. COVID-19-Associated Hospitalizations among Long-Term Care Facility Residents Ages ≥65 Years — COVID-NET, 14 U.S. States, March 2020–January 2022. (15th December 2022)

4. 303. Viral and bacterial infections among adults hospitalized with COVID-19, Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, 14 states, March 2020–February 2022. (15th December 2022)

5. 354. Evidence of Aspergillosis Among Patients With Influenza-Associated Hospitalizations—United States, 2005–2017. (26th November 2018)

6. 647Impact of 13-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in the United States. (December 2014)

8. 70. Changes in Invasive Pneumococcal Disease among Adults Living with HIV Following Introduction of 13-Valent Pneumococcal Conjugate Vaccine, 2008–2018. (4th December 2021)

9. 70. Changes in Invasive Pneumococcal Disease among Adults Living with HIV Following Introduction of 13-Valent Pneumococcal Conjugate Vaccine, 2008–2018. (4th December 2021)

10. 79Prevention of Antimicrobial Resistant Infection Among Children Aged <5 Years with the 13-valent Pneumococcal Conjugate Vaccine – Selected U.S. Areas, 2005–2013. (December 2014)